Home › Funds › Man Group plc › GILD

Man Group plc position in GILD

GILEAD SCIENCES INC · Health Care

Man Group plc reported holding 1,235,196 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$156.1M, representing 0.44% of its reported portfolio and ranking #45 among its reported holdings. Man Group plc has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.24M sh
Reported value held$156.05M
Portfolio Weight0.44%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Man Group plc's GILD position evolved

Man Group plc first disclosed a stake in GILD in Q3 2023 at 572,498 shares (US$42.9M). The position peaked in Q4 2025 at 1,725,112 shares, worth US$211.7M. Across 12 filings, Man Group plc increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,235,196 shares valued at US$156.1M — an increase of 557,130 shares quarter over quarter.. Notable position changes include a 116% increase in Q1 2024 (shares fell 6% over the following quarter), a 91% increase in Q1 2025 (shares were roughly flat over the following quarter), a 82% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 572.50K $42.90M New
Q4 2023 459.35K $37.21M Reduce
Q1 2024 991.32K $72.61M Add
Q2 2024 1.19M $81.62M Add
Q3 2024 629.61K $52.79M Reduce
Q4 2024 873.18K $80.66M Add
Q1 2025 1.66M $186.52M Add
Q2 2025 1.57M $174.62M Reduce
Q3 2025 1.76M $194.98M Add
Q4 2025 1.73M $211.74M Reduce
Q1 2026 678.07K $94.50M Reduce
Q2 2026 1.24M $156.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Man Group plc held GILD?

Man Group plc has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Man Group plc's current position in GILD?

As of Q2 2026, Man Group plc holds 1.24M shares of GILD (GILEAD SCIENCES INC), valued at $156.05M, representing 0.44% of its reported portfolio and ranking #45.

Has Man Group plc been buying or selling GILD?

In the latest 13F filing (Q2 2026), Man Group plc increased its position in GILD. The position peaked in Q4 2025 at 1.73M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.